The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
Abstract
These evidence-based guidelines have been produced after a literature review of the treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA) infection. The guidelines were further informed by antibiotic susceptibility data on MRSA from the UK. Recommendations are given for the treatment of common infections caused by MRSA, elimination of MRSA from carriage sites and prophylaxis of surgical site infection. There are several antibiotics currently available that are suitable for use in the management of this problem and potentially useful new agents are continuing to emerge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guideline for Prevention of Surgical Site Infection, 1999
Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., Jarvis, W. R., & The Hospital Infection Control Practices Advisory Committee (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501620 · Cited by 4,595
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Ledell, K., Muto, C. A., Jarvis, W. R., & Farr, B. M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502924 · Cited by 1,192
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
Methicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Salgado, C. D., Farr, B. M., & Calfee, D. P. (2003) · Clinical Infectious Diseases · doi:10.1086/345436 · Cited by 790
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Self-citationWunderink, R. G., Rello, J., Cammarata, S., et al. (2003) · PubMed · Cited by 566
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Stevens, D. L., Herr, D., Lampiris, H., Hunt, J. L., Batts, D. H., Hafkin, B., & the Linezolid MRSA Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/340353 · Cited by 506
Blot, S. I., Vandewoude, K. H., Hoste, E. A., & Colardyn, F. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2229 · Cited by 463
Hematologic Effects of Linezolid: Summary of Clinical Experience
Gerson, S. L., Kaplan, S. L., Bruss, J. B., Le, V., Arellano, F. M., Hafkin, B., & Kuter, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2723-2726.2002 · Cited by 443
Rubinstein, E., Cammarata, S. K., Oliphant, T. H., Wunderink, R. G., & the Linezolid Nosocomial Pneumonia Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/318486 · Cited by 440
Rybak, M. J., Abate, B. J., Kang, S. L., Ruffing, M. J., Lerner, S. A., & Drusano, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1549 · Cited by 431
Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Fowler, V. G., Li, J., Corey, G. R., Boley, J., Marr, K. A., Gopal, A. K., Kong, L. K., Gottlieb, G., Donovan, C. L., Sexton, D. J., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00250-7 · Cited by 423
Mart??nez-Aguilar, G., Avalos-Mishaan, A., Hulten, K., Hammerman, W., Mason, E. O., & Kaplan, S. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133044.79130.2a · Cited by 416
Brown, D. F. J., Edwards, D. I., Hawkey, P. M., Morrison, D., Ridgway, G. L., Towner, K. J., & Wren, M. W. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki372 · Cited by 410
Self-citationGonzalez, C., Rubio, M., Romero-Vivas, J., Gonzalez, M., & Picazo, J. J. (1999) · Clinical Infectious Diseases · doi:10.1086/313440 · Cited by 407
Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureus
Tenover, F. C., Biddle, J. W., & Lancaster, M. V. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010237 · Cited by 391
Wysocki, M., Delatour, F., Faurisson, F., Rauss, A., Pean, Y., Misset, B., Thomas, F., Timsit, J.-F., Similowski, T., Mentec, H., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2460-2467.2001 · Cited by 385
Ayliffe, P. G. A. J., Buckles, M. A., Casewell, M. W., Cookson, B. D., Cox, R. A., Duckworth, G. J., French, G. L., Griffiths-Jones, M. A., Heathcock, R., Humphreys, H., et al. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90293-6 · Cited by 370
Kalmeijer, M. D., Coertjens, H., van Nieuwland‐Bollen, P. M., Bogaers‐Hofman, D., de Baere, G. A. J., Stuurman, A., van Belkum, A., & Kluytmans, J. A. J. W. (2002) · Clinical Infectious Diseases · doi:10.1086/341025 · Cited by 348
Fridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M., Tenover, F. C., & the Vancomycin‐Intermediate Staphylococcus aureus Epidemiology Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/346207 · Cited by 344
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
Moise-Broder, P. A., Sakoulas, G., Eliopoulos, G. M., Schentag, J. J., Forrest, A., & Moellering, R. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421092 · Cited by 332
GRUSON, D., HILBERT, G., VARGAS, F., VALENTINO, R., BEBEAR, C., ALLERY, A., BEBEAR, C., GBIKPI-BENISSAN, G., & CARDINAUD, J.-P. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9905050 · Cited by 328
Managing skin and soft tissue infections: expert panel recommendations on key decision points
Eron, L. J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg466 · Cited by 319
Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Romero-Vivas, J., Rubio, M., Fernandez, C., & Picazo, J. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1417 · Cited by 318
Wunderink, R. G., Rello, J., Cammarata, S. K., Croos-Dabrera, R. V., & Kollef, M. H. (2003) · Chest · doi:10.1016/s0012-3692(15)33412-7 · Cited by 317
Kollef, M. H., Rello, J., Cammarata, S. K., Croos-Dabrera, R. V., & Wunderink, R. G. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2088-1 · Cited by 315
MARTÍNEZ-AGUILAR, G., HAMMERMAN, W. A., MASON, E. O., & KAPLAN, S. L. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073163.37519.ee · Cited by 315
Methicillin-Resistant Staphylococcus aureus
Boyce, J. M. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30313-5 · Cited by 312
WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Maple, P. A. C., Hamilton-Miller, J. M. T., & Brumfitt, W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90076-7 · Cited by 312
Lipsky, B. A., Itani, K., Norden, C., & the Linezolid Diabetic Foot Infections Study Group (2004) · Clinical Infectious Diseases · doi:10.1086/380449 · Cited by 311
Harbarth, S., Dharan, S., Liassine, N., Herrault, P., Auckenthaler, R., & Pittet, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1412 · Cited by 286
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
FRANK, A. L., MARCINAK, J. F., MANGAT, P. D., TJHIO, J. T., KELKAR, S., SCHRECKENBERGER, P. C., & QUINN, J. P. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200206000-00010 · Cited by 271
Treatment and Outcome of Staphylococcus aureus Bacteremia: A Prospective Study of 278 Cases
Jensen, A. G., Wachmann, C. H., Espersen, F., Scheibel, J., Skinhøj, P., & Frimodt-Møller, N. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.1.25 · Cited by 270
Harbarth, S., Rutschmann, O., Sudre, P., & Pittet, D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.2.182 · Cited by 267
Fowler, V. G., Justice, A., Moore, C., Benjamin, D. K., Woods, C. W., Campbell, S., Reller, L. B., Corey, G. R., Day, N. P. J., & Peacock, S. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427806 · Cited by 262
Cox, R. A., Conquest, C., Mallaghan, C., & Marples, R. R. (1995) · Journal of Hospital Infection · doi:10.1016/0195-6701(95)90191-4 · Cited by 261
Daptomycin‐Resistant, Methicillin‐Resistant Staphylococcus aureus Bacteremia
Mangili, A., Bica, I., Snydman, D. R., & Hamer, D. H. (2005) · Clinical Infectious Diseases · doi:10.1086/428616 · Cited by 256
Katlama, C., De Wit, S., O'Doherty, E., Van Glabeke, M., Clumeck, N., & European Network for Treatment of AIDS (ENTA) Toxoplasmosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.268 · Cited by 253
Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro
Amorena, B., Gracia, E., Monzón, M., Leiva, J., Oteiza, C., Pérez, M., Alabart, J.-L., & Hernández-Yago, J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.43 · Cited by 247
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, Jr., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 247
Johnson, A. P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.143 · Cited by 247
Melzer, M., Eykyn, S. J., Gransden, W. R., & Chinn, S. (2003) · Clinical Infectious Diseases · doi:10.1086/379321 · Cited by 241
Scanvic, A., Denić, L. M., Gaillon, S., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/320151 · Cited by 234
Shlaes, D. M., Gerding, D. N., John, J. F., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Infection Control and Hospital Epidemiology · doi:10.2307/30141215 · Cited by 233
Seltzer, E., Dorr, M. B., Goldstein, B. P., Perry, M., Dowell, J. A., Henkel, T., & Dalbavancin Skin and Soft-Tissue Infection Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/379015 · Cited by 231
Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus
(1990) · Journal of Hospital Infection · doi:10.1016/0195-6701(90)90008-c · Cited by 231
Prosthetic Joint Infection: When Can Prosthesis Salvage Be Considered?
Tattevin, P., Crémieux, A., Pottier, P., Huten, D., & Carbon, C. (1999) · Clinical Infectious Diseases · doi:10.1086/520202 · Cited by 229
Wunderink, R. G., Cammarata, S. K., Oliphant, T. H., & Kollef, M. H. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80118-2 · Cited by 229
FAGON, J.-Y., PATRICK, H., HAAS, D. W., TORRES, A., GIBERT, C., CHEADLE, W. G., FALCONE, R. E., ANHOLM, J. D., PAGANIN, F., FABIAN, T. C., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9904115 · Cited by 214
Glycopeptide Antibiotics: from Conventional Molecules to New Derivatives
Van Bambeke, F., Van Laethem, Y., Courvalin, P., & Tulkens, P. M. (2004) · Drugs · doi:10.2165/00003495-200464090-00001 · Cited by 213
Reed, S. D., Friedman, J. Y., Engemann, J. J., Griffiths, R. I., Anstrom, K. J., Kaye, K. S., Stryjewski, M. E., Szczech, L. A., Reller, L. B., Corey, G. R., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502523 · Cited by 200
Community-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen
Saïd-Salim, B., Mathema, B., & Kreiswirth, B. N. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502231 · Cited by 198
Risk Factors for Persistent Carriage of Methicillin‐Resistant Staphylococcus aureus
Harbarth, S., Liassine, N., Dharan, S., Herrault, P., Auckenthaler, R., & Pittet, D. (2000) · Clinical Infectious Diseases · doi:10.1086/317484 · Cited by 197
Linezolid Resistance inStaphylococcus aureus:Characterization and Stability of Resistant Phenotype
Pillai, S. K., Sakoulas, G., Wennersten, C. B., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/345368 · Cited by 193
Staphylococcus aureus Bacteremia: Predictors of 30-Day Mortality in a Large Cohort
Mylotte, J. M., & Tayara, A. (2000) · Clinical Infectious Diseases · doi:10.1086/317421 · Cited by 190
Rosen, A. B., Fowler, V. G., Corey, G. R., Downs, S. M., Biddle, A. K., Li, J., & Jollis, J. G. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00004 · Cited by 186
Quinupristin‐Dalfopristin and Linezolid: Evidence and Opinion
Eliopoulos, G. M. (2003) · Clinical Infectious Diseases · doi:10.1086/367662 · Cited by 169
Harbarth, S., Harris, A. D., Carmeli, Y., & Samore, M. H. (2001) · Clinical Infectious Diseases · doi:10.1086/322677 · Cited by 169
Mody, L., Kauffman, C. A., McNeil, S. A., Galecki, A. T., & Bradley, S. F. (2003) · Clinical Infectious Diseases · doi:10.1086/379325 · Cited by 167
Wilcox, M. H., Hall, J., Pike, H., Templeton, P. A., Fawley, W. N., Parnell, P., & Verity, P. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00147-6 · Cited by 166
Ruhe, J. J., Monson, T., Bradsher, R. W., & Menon, A. (2005) · Clinical Infectious Diseases · doi:10.1086/429628 · Cited by 166
Drew, R. H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.775 · Cited by 165
Landman, D., Chockalingam, M., & Quale, J. M. (1999) · Clinical Infectious Diseases · doi:10.1086/514743 · Cited by 161
Hill, R. L. R., Duckworth, G. J., & Casewell, M. W. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.3.377 · Cited by 158
Carmeli, Y., Eliopoulos, G. M., & Samore, M. H. (2002) · Emerging infectious diseases · doi:10.3201/eid0808.010418 · Cited by 158
Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J. (2004) · Clinical Infectious Diseases · doi:10.1086/380125 · Cited by 156
Stein, A., Bataille, J. F., Drancourt, M., Curvale, G., Argenson, J., Groulier, P., & Raoult, D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3086 · Cited by 150
The VISA/GISA problem: therapeutic implications
Liñares, J. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00054.x · Cited by 145
A twelve-year review of central nervous system bacterial abscesses; presentation and aetiology
Roche, M., Humphreys, H., Smyth, E. G., Phillips, J., Cunney, R., McNamara, E., O’Brien, D. P., & McArdle, O. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00651.x · Cited by 145
Walsh, T. J., Standiford, H. C., Reboli, A. C., John, J. F., Mulligan, M. E., Ribner, B. S., Montgomerie, J. Z., Goetz, M. B., Mayhall, C. G., & Rimland, D. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1334 · Cited by 145
Vancomycin concentrations in infected and noninfected human bone
Graziani, A. L., Lawson, L. A., Gibson, G. A., et al. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1320 · Cited by 145
Carmeli, Y., Samore, M. H., & Huskins, W. C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.20.2461 · Cited by 145
Linezolid eradicates MRSA better than vancomycin from surgical-site infections
Weigelt, J. A., Kaafarani, H. M. A., Itani, K. M. F., & Swanson, R. N. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2004.08.045 · Cited by 145
Levin, T. P., Suh, B., Axelrod, P. I., Truant, A. L., & Fekete, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1222-1224.2005 · Cited by 144
Chuard, C., Herrmann, M., Vaudaux, P., Waldvogel, F. A., & Lew, D. P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2611 · Cited by 143
Lucet, J. C., Herrmann, M., Rohner, P., Auckenthaler, R., Waldvogel, F. A., & Lew, D. P. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2312 · Cited by 142
Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis
Høiby, N., Jarløv, J. O., Kemp, M., Tvede, M., Bangsborg, J., Kjerulf, A., Pers, C., & Hansen, H. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09229-x · Cited by 141
Schentag, J. J., Hyatt, J. M., Carr, J. R., Paladino, J. A., Birmingham, M. C., Zimmer, G. S., & Cumbo, T. J. (1998) · Clinical Infectious Diseases · doi:10.1086/520287 · Cited by 140
Mupirocin-Resistant, Methicillin-ResistantStaphylococcus aureus: Does Mupirocin Remain Effective?
Walker, E. S., Vasquez, J. E., Dula, R., et al. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502218 · Cited by 137
Elliott, T., Foweraker, J. E., Gould, F. K., Perry, J. D., & Sandoe, J. A. T. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh474 · Cited by 137
Self-citationInterpretive criteria for testing susceptibility of staphylococci to mupirocin
Finlay, J., Miller, L. A., & Poupard, J. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1137 · Cited by 135
Calfee, D. P., Durbin, L. J., Germanson, T. P., TONEY, D. M., Smith, E. B., & Farr, B. M. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502225 · Cited by 131
Li, Z., Willke, R. J., Pinto, L. A., Rittenhouse, B., Rybak, M. J., Pleil, A. M., Crouch, C. W., Hafkin, B., & Glick, H. A. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.3.263.34198 · Cited by 130
Tennent, J. M., Lyon, B. R., Gillespie, M. T., May, J. W., & Skurray, R. A. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.1.79 · Cited by 130
Parras, F., Guerrero, M. C., Bouza, E., Blázquez, M. J., Moreno, S., Menárguez, M. C., & Cercenado, E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.175 · Cited by 127
Tacconelli, E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh107 · Cited by 127
Fortún, J., Navas, E., Martínez‐Beltrán, J., Pérez‐Molina, J., Martín‐Dávila, P., Guerrero, A., & Moreno, S. (2001) · Clinical Infectious Diseases · doi:10.1086/320869 · Cited by 126
Zimmermann, A. E., Katona, B. G., & Plaisance, K. I. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04335.x · Cited by 122
de la Cal, M. A., Cerdá, E., SAENE, H. K. F. V., García-Hierro, P., Negro, E., Parra, M. L., Arias-Rivera, S., & Ballesteros, D. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.09.021 · Cited by 121
Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Myers, J. P., & Linnemann, C. C. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/145.4.532 · Cited by 120
Dziekan, G., Hahn, A., Thüne, K., Schwarzer, G., Schäfer, K., Daschner, F. D., & Grundmann, H. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0846 · Cited by 120
Jernigan, J. A., Pullen, A. L., Flowers, L., Bell, M. R., & Jarvis, W. R. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502230 · Cited by 116
Glycopeptides in clinical development: pharmacological profile and clinical perspectives
Françoise Van Bambeke, A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.04.006 · Cited by 114
Cepeda, J. A., Whitehouse, T., Cooper, B., Hails, J., Jones, K., Kwaku, F., Taylor, L., Hayman, S., Shaw, S., Kibbler, C., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh048 · Cited by 114
Therapy of Staphylococcus aureus Bacteremia Associated with a Removable Focus of Infection
Iannini, P. B., & Crossley, K. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-5-558 · Cited by 112
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh088 · Cited by 112
Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections
Moise, P. A., & Schentag, J. J. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00303-4 · Cited by 112
Vancomycin toxicity: a prospective study
Mellor, J., Kingdom, J. C., CAFFERKEY, M. T., & Keane, C. T. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.6.773 · Cited by 110
Gilbert, D. N., Wood, C. A., & Kimbrough, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.79 · Cited by 109
Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus
Rimland, D., & Roberson, B. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.1.137-138.1986 · Cited by 107
Bayer, A. S., & Lam, K. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.1.157 · Cited by 104
Campillo, B., Dupeyron, C., & Richardet, J. P. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801006288 · Cited by 98
Monnet, D. L. (1998) · Infection Control and Hospital Epidemiology · doi:10.1086/647872 · Cited by 98
Müller, A., Mauny, F., Bertin, M., Cornette, C., López-Lozano, J.-M., Viel, J., Talon, D. R., & Bertrand, X. (2003) · Clinical Infectious Diseases · doi:10.1086/374221 · Cited by 96
Moore, P. C. L., & Lindsay, J. A. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-6-516 · Cited by 95
The Decline of Methicillin Resistance Among Danish Staphylococcus Aureus Strains
Rosdahl, V. T., & Knudsen, A. M. (1991) · Infection Control and Hospital Epidemiology · doi:10.1086/646291 · Cited by 93
Why monitor peak vancomycin concentrations?
Saunders, N. J. S. G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92890-8 · Cited by 92
Silvestri, L., Milanese, M., Oblach, L., Fontana, F., Gregori, D., Guerra, R., & van Saene, H. K. F. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.122255 · Cited by 91
Moise, P. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf215 · Cited by 89
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
Gilligan, P. H., Gage, P. A., Welch, D. F., Muszynski, M. J., & Wait, K. J. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.7.1258-1261.1987 · Cited by 87
McHugh, C. G., & Riley, L. W. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502417 · Cited by 87
Fukuda, M., Ohashi, H., Matsumoto, C., Mishima, S., & Shimomura, Y. (2002) · Cornea · doi:10.1097/01.ico.0000263125.99262.42 · Cited by 83
Clark, N. C., Weigel, L. M., Patel, J. B., & Tenover, F. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.470-472.2005 · Cited by 82
Johnson, L. B., Almoujahed, M. O., ILG, K. J., Maolood, L., & Khatib, R. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016682 · Cited by 81
Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections
Piercy, E. A., Barbaro, D., Luby, J. P., & Mackowiak, P. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.128 · Cited by 81
Stamm, A. M., Long, M. N., & Belcher, B. (1993) · American Journal of Infection Control · doi:10.1016/0196-6553(93)90227-u · Cited by 80
Kim, H. B., Park, W.-B., Lee, K.-D., Kang, C.-I., Bang, J.-W., Hong-Bin, K., Kim, E.-C., Oh, M.-D., & Kang-Won, C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh366 · Cited by 80
Transferable resistance to triclosan in MRSA
Cookson, B., Farrelly, H. D., Stapleton, P. D., Garvey, R., & Price, M. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)93242-2 · Cited by 78
Dworkin, R. J., Modin, G. W., Kunz, S., Rich, R., Zak, O., & Sande, M. A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1014 · Cited by 78
Hitomi, S., Kubota, M., Mori, N., Baba, S., Yano, H., Okuzumi, K., & Kimura, S. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0786 · Cited by 76
Susceptibility of antibiotic-resistant cocci to biocides
Fraise, A. P. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.2.x · Cited by 74
Self-citationTownsend, D. E., Ashdown, N., Greed, L. C., et al. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.2.115 · Cited by 74
Burnie, J., Matthews, R., Jiman-Fatami, A., Gottardello, P., Hodgetts, S. J., & D’Arcy, S. (2000) · Clinical Infectious Diseases · doi:10.1086/314035 · Cited by 70
JANTAUSCH, B. A., Deville, J. G., Adler, S. P., MORFIN, M. R., López, P., EDGE-PADBURY, B., NABERHUIS-STEHOUWER, S., & BRUSS, J. B. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000086956.45566.55 · Cited by 69
Lodise, T. P., McKinnon, P. S., & Rybak, M. J. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502269 · Cited by 68
Tobin, C. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf212 · Cited by 67
Irizarry, L., Merlin, T. L., Rupp, J., & Griffith, J. K. (2009) · Chemotherapy · doi:10.1159/000239451 · Cited by 62
van der Auwera, P., Aoun, M., & Meunier, F. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.451 · Cited by 62
Boelaert, J. R., Landuyt, H. W. V., Gordts, B., Baere, Y. A. D., Messer, S. A., & Herwaldt, L. A. (1996) · Infection Control and Hospital Epidemiology · doi:10.1086/647241 · Cited by 62
Vriens, M. R., Fluit, A. C., Troelstra, A., et al. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502094 · Cited by 61
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN DUBLIN 1971-84
Cafferkey, M., Coleman, D. C., Mcgrath, B., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92942-3 · Cited by 59
Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases
Wilson, A. P. R., & Gaya, H. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.3.507 · Cited by 58
Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis
Graninger, W. B., Wenisch, C., Wiesinger, E., et al. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690746 · Cited by 57
Cohen, E. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.155 · Cited by 57
Dupeyron, C., Campillo, B., Bordes, M., Faubert, E., Richardet, J. P., & Mangeney, N. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1287 · Cited by 54
DECLINE OF THE HOSPITAL STAPHYLOCOCCUS?
Ayliffe, G. A. J., Lilly, H. A., & Lowbury, E. J. L. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90955-3 · Cited by 53
Re-emergence of methicillin-resistant staphylococcus aureus causing severe infection
Keane, C. T., & CAFFERKEY, M. T. (1984) · Journal of Infection · doi:10.1016/s0163-4453(84)94368-8 · Cited by 52
Murchan, S., Aucken, H. M., O'Neill, G. L., Ganner, M., & Cookson, B. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5154-5160.2004 · Cited by 52
Decreased Antimicrobial Resistance after Changes in Antibiotic Use
Smith, D. W. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.12.129s.31702 · Cited by 52
Understanding and Controlling Methicillin-ResistantStaphylococcus aureusInfections
Boyce, J. M. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502092 · Cited by 46
The Decline of Methicillin Resistance among Danish Staphylococcus aureus Strains
Rosdahl, V. T., & Knudsen, A. M. (1991) · Infection Control and Hospital Epidemiology · doi:10.2307/30147049 · Cited by 46
Treatment of severe staphylococcal infections with a rifampicin-minocycline association
Clumeck, N., Marcelis, L., Mh, A.-L., & Gordts, B. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/13.suppl_c.17 · Cited by 45
Cartolano, G.-L., Cheron, M., Benabid, D., Leneveu, M., & Boisivon, A. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00830.x · Cited by 44
Eng, R. H. K., SMITH, S. G., Tillem, M., & Cherubin, C. E. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360010188034 · Cited by 42
Nasal Disinfection in Prevention of Post-operative Staphylococcal Infection of Wounds
Henderson, R. J., & Williams, R. E. O. (1961) · BMJ · doi:10.1136/bmj.2.5248.330 · Cited by 41
Topical Mupirocin for Eradication of MRSA Colonization With Mupirocin-Resistant Strains
Semret, M., & Miller, M. A. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501956 · Cited by 37
Denis, O., Deplano, A., Ryck, R. D., Nonhoff, C., & Struelens, M. J. (2003) · Microbial Drug Resistance · doi:10.1089/107662903764736355 · Cited by 35
Maraha, B., van Halteren, J., Verzijl, J. M., Wintermans, R. G. F., & Buiting, A. G. M. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00404.x · Cited by 34
Mayall, B. C., Martín, R., Keenan, A. M., Irving, L. B., Leeson, P., & Lamb, K. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90036-5 · Cited by 34
Svensson, E., Hanberger, H., Nilsson, M., et al. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.6.817 · Cited by 34
Sander, A., Beiderlinden, M., Schmid, E., & Peters, J. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1358-7 · Cited by 29
Davey, P. G., & Williams, A. H. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_b.43 · Cited by 28
Fantin, B., Leclercq, R., Duval, J., et al. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2466 · Cited by 28
Special Considerations for Monitoring Vancomycin Concentrations in Pediatric Patients
Miles, M. V., Li, L., Lakkis, H. D., et al. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199706000-00004 · Cited by 26
Nonhoff, C., Denis, O., & Struelens, M. J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01060.x · Cited by 22
Merrer, J., Pisica–Donose, G., Leneveu, M., & Pauthier, F. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502432 · Cited by 22
Lacy, M. K., Tessier, P. R., Nicolau, D. P., Nightingale, C. H., & Quintiliani, R. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00121-7 · Cited by 16
Stokes, E. J., & Milne, S. E. (1962) · Journal of Hygiene · doi:10.1017/s0022172400039474 · Cited by 16
Rountree, P. M., Loewenthal, J., Tedder, E., et al. (1962) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb20319.x · Cited by 14
Jonas, D., Towner, K. J., Loerwald, M., Shunburne, L., Schmidt-Wieland, T., & Daschner, F. D. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0842-x · Cited by 8
Jj, G., Regnier, B., Lassoued, K., et al. (1985) · PubMed · Cited by 8
The Intraocular Penetration and Retinal Toxicity of Teicoplanin
Carney, M. D., Kao, G., Peyman, G. A., Fiscella, R. G., & Staneck, J. L. (1988) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/1542-8877-19880201-11 · Cited by 8
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Clinical practice guidelines for antimicrobial prophylaxis in surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120568 · Cited by 2,591
Duncan, T. V. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.07.017 · Cited by 2,029
Metadata
- Authors
- Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-28
- Volume
- 57
- Issue
- 4
- Pages
- 589-608
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2134827823
- Cited by
- 439
- References
- 177
- FWCI
- 23.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.